The Readout Loud 297: VC turmoil, GLP-1 competition, & the war on recovery
Mar 7, 2024
Exploring barriers to using life-saving tools in combating opioid overdose epidemic, trends in venture capital financing in the biotech industry, Novo Nordisk's promising oral medication for obesity, and the critical role of methadone and buprenorphine in reducing opioid deaths.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 2min
Trends in Venture Capital Financing and Biotech IPOs
01:53 • 6min
In-depth analysis of Novo Nordisk's new oral medication for obesity
07:29 • 3min
Pharmaceutical Valuation and Acquisition Trends in the Industry
10:08 • 1min
The Lifesaving Potential of Methadone and Buprenorphine
11:29 • 13min
Exploring the Potential for Change in Healthcare Policy
24:37 • 3min